DSM-Firmenich
€97.58Change from previous close: −0.45%Absolute change: −€0.44
At a glance
- Revenue growth
- −0.22%
- 2025 vs 2024
- Net margin
- -12.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 9,034 | 9,054 | 10,627 | 8,390 | — |
| Cost of revenue | 5,504 | 5,501 | 8,016 | 5,700 | — |
| Gross profit | 3,530 | 3,553 | 2,611 | 2,690 | — |
| Selling, general and administrative | 2,206 | 2,204 | 2,527 | 1,769 | — |
| Research and development | 713 | 814 | 652 | 295 | — |
| Operating income | 632 | 551 | -507 | 657 | — |
| EBIT | 727 | 588 | -479 | 724 | — |
| EBITDA | 3,849 | 1,774 | 501 | 1,376 | — |
| Interest expense | 159 | 165 | 168 | 130 | — |
| Pre-tax income | 568 | 423 | -647 | 594 | — |
| Income tax | 118 | 64.0 | -18.0 | 124 | — |
| Net income | -1,081 | 250 | 2,137 | 1,700 | — |
| Net income to common shareholders | -1,107 | 222 | 2,131 | 1,694 | — |
| Basic EPS | -4.27 | 0.84 | 9.14 | 11.24 | — |
| Diluted EPS | -4.27 | 0.84 | 9.13 | 11.24 | — |
| Average shares (basic) | 259 | 265 | 233 | 151 | — |
| Average shares (diluted) | 259 | 265 | 233 | 151 | — |